FindTrial
Sign In

Role of screening method to assess changes in menstrual diseases

Palmer Dermatoglyphics for screening Aartav Vaha Srotovikar with special reference to Polycystic Ovarian Syndrome - A Cross Sectional Study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/084472
Enrollment
208
Registered
2025-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N832- Other and unspecified ovarian cysts

Interventions

None listed

Sponsors

Dr Smitaraje D Wader
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed patients of Polycystic Ovarian Syndrome with symptoms of Anartava Nashtartava Aartavakshaya Aniyamit Aartava Aartavativrudhi Vandhyatva Healthy females age matched and those who do not have symptoms of Polycystic Ovarian Syndrome

Exclusion criteria

Exclusion criteria: Female patients with history of Congenital deformity related to Uterus Ovary Fallopian tubes Cervix Vagina History of Hysterectomy History of Cancer Skin diseases of hand Deformity of hands amputed hands and amputed fingers Injuries and scars of hands Females of Polycystic Ovarian Syndrome with genetic disorder Obese females with Polycystic Ovarian Syndrome

Design outcomes

Primary

MeasureTime frame
Fingertip pattern frequencyTimepoint: At Baseline—

Secondary

MeasureTime frame
a Main line formula b Main line index c Three angles d Interdigital ridge count e Total finger ridge count f Absolute finger ridge count g Three IndexTimepoint: At baseline—

Countries

India

Contacts

Public ContactDr Pradeep Shindhe

KAHER shri BMK Ayurved Mahavidyalaya Shahapur Belagavi

pshindhe@gmail.com9986331357

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026